Categories AlphaGraphs, Earnings, LATEST, Other Industries
Botox, Juvederm sales lift Allergan in first quarter
Allergan plc (AGN) reported a 3% improvement in revenues to $3.7 billion for the first quarter of 2018 compared to the prior year period, driven by a 13% increase in its core business which includes the Botox and Juvederm brands.
Net loss for the quarter was $332.5 million or $0.99 per diluted share compared to $2.6 billion or $7.86 per diluted share for the same period last year. Adjusted EPS totaled $3.74.
Revenue and adjusted EPS figures beat market estimates, sending shares up by more than 3% in premarket trade.
US Specialized Therapeutics revenues grew 6.5% while U.S. General Medicine fell 9.1% compared to the prior year period. International revenues rose 9%.
In the US, BOTOX Cosmetic net revenues rose 7% while JUVEDERM Collection revenues grew 2.5% versus last year. BOTOX Therapeutic revenues increased more than 16% with growth in chronic migraine, overactive bladder, and adult spasticity indications.
Internationally, BOTOX Cosmetic grew 15.3% with strong growth in all regions while BOTOX Therapeutic revenues rose 8.5%, reflecting strong growth in Europe and Latin America/Canada.
During the quarter, Allergan announced positive top line results in the second of two pivotal phase 3 clinical trials evaluating Ubrogepant for the acute treatment of migraine. Allergan anticipates filing of a New Drug Application (NDA) to the US Food and Drug Administration in 2019.
On a GAAP basis, for the second quarter of 2018, Allergan expects net revenues of $3.8 billion to $4 billion and net loss per share between $0.49 and $0.69. For full-year 2018, net revenues are expected to be $15.1-$15.3 billion, and net loss per share is expected to be in the $2.20-$2.81 range.
Most Popular
PG Earnings: Procter & Gamble Q3 profit climbs, beats estimates
Consumer goods behemoth The Procter & Gamble Company (NYSE: PG) announced financial results for the third quarter of 2024, reporting a double-digit growth in net profit. Sales rose modestly. Core
AXP Earnings: All you need to know about American Express’ Q1 2024 earnings results
American Express Company (NYSE: AXP) reported its first quarter 2024 earnings results today. Consolidated total revenues, net of interest expense, increased 11% year-over-year to $15.8 billion, driven mainly by higher
Netflix (NFLX) Q1 2024 profit tops expectations; adds 9.3Mln subscribers
Streaming giant Netflix, Inc. (NASDAQ: NFLX) Thursday reported a sharp increase in net profit for the first quarter of 2024. Revenues were up 15% year-over-year. Both numbers exceeded Wall Street's